Knowledge of hepatitis C and treatment willingness amongst people who inject drugs in an era of direct acting antivirals
Datos Bibliográficos
| ID | 14905575 |
|---|---|
| Autores | Allison Mah (0000-0003-0158-2324, University of British Columbia), Mark Hull (0000-0002-9234-3531, University of British Columbia), Mark W Hull, Kora Debeck (0000-0003-2045-1653, University of British Columbia), Michael John Milloy (University of British Columbia), Sabina Dobrer (St. Paul's Hospital), Ekaterina Nosova (0000-0002-4474-2757, St. Paul's Hospital), Evan Wood (0000-0001-9412-6699, University of British Columbia), Thomas Kerr (0000-0002-0870-7153, University of British Columbia), K Hayashi (0000-0003-3843-2928, Simon Fraser University, autor de correspondencia) |
| Año | 2017 |
| Volumen | 47 |
| Páginas | 137-143 |
| Fecha de publicación | 2017-09-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2017.02.006 |
| PMID | 28347636 |
| OpenAlex | W2597420014 |
| Idioma | EN |
| Citas recibidas | 10 |
| Referencias citadas | 30 |
Cohort · Confidence interval · Hepatitis C · Hepatitis C virus · Residence · Virus · Demography · Hepatitis B Virus Studies · Hepatitis C virus research · HIV, Drug Use, Sexual Risk · Medicine · Immunology · Internal Medicine
Hepatitis C antibody prevalence and behavioral correlates in people who inject drugs attending harm reduction services in Lisbon, Portugal
Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness
Long‐Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response
“I want to get better, but…”
Everybody living with a chronic disease is entitled to be cured”
Determinants of hepatitis C antiviral effectiveness awareness among people who inject drugs in the direct-acting antiviral era
Elimination of hepatitis C virus infection among PWID
Hepatitis C care continuum and associated barriers among people who inject drugs in Chennai, India
Conceptualising access in the direct-acting antiviral era
Stigma is where the harm comes from”
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
The Sources of Four Commonly Reported Cutoff Criteria
Barriers to Use of Free Antiretroviral Therapy in Injection Drug Users
Epidemiology and natural history of HCV infection
Improved Survival Among HIV-Infected Individuals Following Initiation of Antiretroviral Therapy
Rates of Disease Progression by Baseline CD4 Cell Count and Viral Load After Initiating Triple-Drug Therapy
Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic
Hepatitis C virus (HCV) disease progression in people who inject drugs (PWID)
Effectiveness of secondary prevention and treatment interventions for crack-cocaine abuse
Liver disease knowledge and acceptability of non-invasive liver fibrosis assessment among people who inject drugs in the drug and alcohol setting
Situation actuelle de l’hépatite C au Canada
| Obras citantes distintas | 10 |
|---|---|
| Citas por año | 1,11 |
| Intervalo de citas | 2017 - 2025 (9) |
| Velocidad de citación | recent |
| Altamente citado | No |
| Tipos de cita | Neutras: 10 |